logo

FDA Calendar

Share
Company Name Merck & Co Inc.
Drug Name DIFICID (sNDA)
Event Name FDA decision on DIFICID tablets and oral suspension for Clostridium difficile infections in children
Event Date 01/24/2020
Outcome Date 01/27/2020
Outcome FDA approved DIFICID on Jan 27, 2020
Drug Status DIFICID is already indicated in adults (18 years of age or older) for treatment of Clostridium difficile-associated diarrhea
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar

>